Advertisement

Substance Use in Pregnancy Among Vulnerable Women Seeking Addiction and Parenting Support

  • Kiri A. Latuskie
  • Tom Leibson
  • Naomi C. Z. Andrews
  • Mary MotzEmail author
  • Debra J. Pepler
  • Shinya ItoEmail author
Original Article

Abstract

Substance use during pregnancy is associated with obstetrical and fetal complications. Though use of some substances is discontinued during pregnancy, use of others persists. Our goal was to characterize substance-specific use and patterns of use throughout pregnancy among vulnerable women who attended an early intervention program for women with substance use issues. Through retrospective analyses of client records (1995–2016; N = 470), results indicated that the greatest number of women continued use of tobacco and cannabis for the duration of pregnancy (n = 232; 84.4% and n = 102; 60.0%, respectively), while the proportion of women continuing opioid use was relatively high (n = 33; 57.9%). Relapse rates were high for women who initially attempted to discontinue use of cocaine, crack cocaine, and heroin. Results can inform intervention and treatment by indicating which substances are more difficult to discontinue, as well as substances associated with high rates of relapse.

Keywords

Pregnancy Substance use Polysubstance use Prevalence Women 

Notes

Acknowledgements

The authors would like to thank Prateek Lala for his very helpful revisions and suggestions early on in the production of this work.

Funding

This work was supported by the Division of Clinical Pharmacology and Toxicology, the Hospital for Sick Children as well as Mothercraft, Early Intervention Department.

Compliance with Ethical Standards

Ethics approval was obtained from the research ethics board at the Hospital for Sick Children, Toronto, Canada.

Conflicts of Interest

The authors declare that they have no potential conflicts of interest.

References

  1. Aghamohammadi, A., & Zafari, M. (2016). Crack abuse during pregnancy: maternal, fetal and neonatal complication. The Journal of Maternal-Fetal & Neonatal Medicine, 29(5), 795–797.  https://doi.org/10.3109/14767058.2015.1018821.CrossRefGoogle Scholar
  2. American College of Obstetricians and Gynecologists. (2016). ACOG statement on opioid use during pregnancy. Retrieved from https://www.acog.org/About-ACOG/News-Room/Statements/2016/ACOG-Statement-on-Opioid-Use-During-Pregnancy
  3. Andrews, N. C. Z., Motz, M., Pepler, D. J., Jeong, J. J., & Khoury, J. (2018). Engaging mothers with substance use issues and their children in early intervention: understanding use of service and outcomes. Child Abuse and Neglect, 83, 10–20.  https://doi.org/10.1016/j.chiabu.2018.06.011.CrossRefPubMedGoogle Scholar
  4. Avner, M., & Koren, G. (2004). Breaking the cycle - a unique model for FASD research. Journal of FAS International, 1.Google Scholar
  5. Azuma, S. D., & Chasnoff, I. J. (1993). Outcome of children prenatally exposed to cocaine and other drugs: a path analysis of three-year data. Pediatrics, 92(3), 396–402.PubMedGoogle Scholar
  6. Bailey, B. A., McCook, J. G., Hodge, A., & McGrady, L. (2012). Infant birth outcomes among substance using women: why quitting smoking during pregnancy is just as important as quitting illicit drug use. Maternal and Child Health Journal, 16(2), 414–422.  https://doi.org/10.1007/s10995-011-0776-y.CrossRefPubMedGoogle Scholar
  7. Bauer, C. R., Shankaran, S., Bada, H. S., Lester, B., Wright, L. L., Krause-Steinrauf, H., Smeriglio, V. L., Finnegan, L. P., Maza, P. L., & Verter, J. (2002). The maternal lifestyle study: drug exposure during pregnancy and short-term maternal outcomes. American Journal of Obstetrics and Gynecology, 186(3), 487–495.  https://doi.org/10.1067/mob.2002.121073.CrossRefPubMedGoogle Scholar
  8. Bottorff, J. L., Kalaw, C., Johnson, J. L., Stewart, M., & Greaves, L. (2005). Tobacco use in intimate spaces: issues in the study of couple dynamics. Qualitative Health Research, 15(4), 564–577.  https://doi.org/10.1177/1049732304269675.CrossRefPubMedGoogle Scholar
  9. Brands, B., Blake, J., & Marsh, D. (2002). Changing patient characteristics with increased methadone maintenance availability. Drug and Alcohol Dependence, 66, 11–20.  https://doi.org/10.1016/S0376-8716(01)00176-4.CrossRefPubMedGoogle Scholar
  10. Carson, G. (2010). Alcohol use and pregnancy consensus clinical guidelines. Journal of Obstetrics and Gynaecology, 32(8), 1–2.Google Scholar
  11. Castles, A., Adams, E. K., Melvin, C. L., Kelsch, C., & Boulton, M. L. (1999). Effects of smoking during pregnancy: five meta-analyses. American Journal of Preventive Medicine, 16, 208–215.CrossRefPubMedGoogle Scholar
  12. Daley, M., Argeriou, M., & McCarty, D. (1998). Substance abuse treatment for pregnant women: a window of opportunity? Addictive Behaviors, 23(2), 239–249.CrossRefPubMedGoogle Scholar
  13. Daley, M., Argeriou, M., McCarty, D., Callahan, J. J., Shepard, D. S., & Williams, C. N. (2000). The costs of crime and the benefits of substance abuse treatment for pregnant women. Journal of Substance Abuse Treatment, 19(4), 445–458.  https://doi.org/10.1016/S0740-5472(00)00138-0.CrossRefPubMedGoogle Scholar
  14. De Santis, M., De Luca, C., Mappa, I., Quattrocchi, T., Angelo, L., & Cesari, E. (2011). Smoke, alcohol consumption and illicit drug use in an Italian population of pregnant women. European Journal of Obstetrics Gynecology and Reproductive Biology, 159(1), 106–110.  https://doi.org/10.1016/j.ejogrb.2011.07.042.CrossRefGoogle Scholar
  15. Della Grotta, S., LaGasse, L. L., Arria, A. M., Derauf, C., Grant, P., Smith, L. M., Shah, R., Huestis, M., Liu, J., & Lester, B. M. (2010). Patterns of methamphetamine use during pregnancy: results from the infant development, environment, and lifestyle (IDEAL) study. Maternal and Child Health Journal, 14(4), 519–527.  https://doi.org/10.1007/s10995-009-0491-0.CrossRefPubMedGoogle Scholar
  16. Ebrahim, S. H., & Gfroerer, J. (2003). Pregnancy-related substance use in the United States during 1996-1998. Obstetrics and Gynecology, 101(2), 374–379.  https://doi.org/10.1016/S0029-7844(02)02588-7.PubMedCrossRefGoogle Scholar
  17. Edelin, K. C., Gurganious, L., Golar, K., Oellerich, D., Kyei-Aboagye, K., & Hamid, A. (1988). Methadone maintenance in pregnancy: consequences to care and outcome. Obstetrics and Gynecology, 71(3), 399–404.PubMedGoogle Scholar
  18. Eguiagaray, I., Scholz, B., & Giorgi, C. (2016). Sympathy, shame, and few solutions: news media portrayals of fetal alcohol spectrum disorders. Midwifery, 40, 49–54.  https://doi.org/10.1016/j.midw.2016.06.002.CrossRefPubMedGoogle Scholar
  19. Espinet, S. D., Motz, M., Jeong, J. J., Jenkins, J. M., & Pepler, D. (2016). Breaking the cycle’ of maternal substance use through relationships: a comparison of integrated approaches. Addiction Research & Theory, 24(5), 375–388.  https://doi.org/10.3109/16066359.2016.1140148.CrossRefGoogle Scholar
  20. Finnegan, L. (2013). Licit and illicit drug use during pregnancy: maternal, neonatal and early childhood consequences. (Canadian Centre on Substance Abuse, Ed.). Ottawa, ON.Google Scholar
  21. Flemming, K., Graham, H., Heirs, M., Fox, D., & Sowden, A. (2013). Smoking in pregnancy: a systematic review of qualitative research of women who commence pregnancy as smokers. Journal of Advanced Nursing, 69(5), 1023–1036.  https://doi.org/10.1111/jan.12066.CrossRefPubMedGoogle Scholar
  22. Harrison, P. A., & Sidebottom, A. C. (2009). Alcohol and drug use before and during pregnancy: an examination of use patterns and predictors of cessation. Maternal and Child Health Journal, 13(3), 386–394.  https://doi.org/10.1007/s10995-008-0355-z.CrossRefPubMedGoogle Scholar
  23. Havens, J. R., Simmons, L. A., Shannon, L. M., & Hansen, W. F. (2009). Factors associated with substance use during pregnancy: results from a national sample. Drug and Alcohol Dependence, 99, 89–95.  https://doi.org/10.1016/j.drugalcdep.2008.07.010.CrossRefPubMedGoogle Scholar
  24. Hayatbakhsh, M. R., Kingsbury, A. M., Flenady, V., Gilshenan, K. S., Hutchinson, D. M., & Najman, J. M. (2011). Illicit drug use before and during pregnancy at a tertiary maternity hospital 2000-2006. Drug and Alcohol Review, 30(2), 181–187.  https://doi.org/10.1111/j.1465-3362.2010.00214.x.CrossRefPubMedGoogle Scholar
  25. Ko, J. Y., Farr, S. L., Tong, V. T., Creanga, A. A., & Callaghan, W. M. (2015). Prevalence and patterns of marijuana use among pregnant and nonpregnant women of reproductive age. The American Journal of Obstetrics & Gynecology, 213, 201.e1–201.e10.  https://doi.org/10.1016/j.ajog.2015.03.021
  26. Kost, K. (2015). Unintended pregnancy rates at the state level: estimates for 2010 and trends since 2002. (G. Institute, Ed.). New York, NY.Google Scholar
  27. Latuskie, K. A., Andrews, N. C. Z., Motz, M., Leibson, T., Austin, Z., Ito, S., & Pepler, D. J. (2018). Reasons for substance use continuation and discontinuation during pregnancy: a qualitative study. Women and Birth.  https://doi.org/10.1016/j.wombi.2018.04.001.
  28. Lind, J. N., Petersen, E. E., Lederer, P. A., Phillips-Bell, G. S., Perrine, C. G., Li, R., & Anjohrin, S. (2015). Infant and maternal characteristics in neonatal abstinence syndrome - selected hospitals in Florida, 2010-2011. Morbidity and Mortality Weekly Report, 64, 213–216.PubMedPubMedCentralGoogle Scholar
  29. Moore, D. G., Turner, J. D., Parrott, A. C., Goodwin, J. E., Fulton, S. E., Min, M. O., Fox, H. C., Braddick, F. M. B., Axelsson, E. L., Lynch, S., Ribeiro, H., Frostick, C. J., & Singer, L. T. (2010). During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the development and infancy study. Journal of Psychopharmacology, 24(9), 1403–1410.  https://doi.org/10.1177/0269881109348165.CrossRefPubMedGoogle Scholar
  30. Motz, M., Espinet, S. D., Jeong, J. J., Major, D., Racine, N., Chamberlin, J., & Pepler, D. J. (2011). The role of the mother-child relationship in developmental outcomes of infants and young children with and without prenatal alcohol exposure. Journal of Population Therapeutics and Clinical Pharmacology, 18(3), 544–563.Google Scholar
  31. Motz, M., Leslie, M., Pepler, D., Moore, T., & Freeman, P. (2006). Breaking the cycle: measures of progress 1995-2005. Journal of FAS International, 4, 1–134.Google Scholar
  32. Paone, D., & Alperen, J. (1998). Pregnancy policing: policy of harm. International Journal of Drug Policy, 9(2), 101–108.  https://doi.org/10.1016/S0955-3959(98)00006-1.CrossRefGoogle Scholar
  33. Pinto, S. M., Dodd, S., Walkinshaw, S. A., Siney, C., Kakkar, P., & Mousa, H. A. (2010). Substance abuse during pregnancy: effect on pregnancy outcomes. European Journal of Obstetrics Gynecology and Reproductive Biology, 150(2), 137–141.  https://doi.org/10.1016/j.ejogrb.2010.02.026.CrossRefGoogle Scholar
  34. Public Health Agency of Canada. (2009). What mothers say: The Canadian maternity experiences survey. Ottawa, ON.Google Scholar
  35. Racine, N., Motz, M., Leslie, M., & Pepler, D. J. (2009). Breaking the cycle pregnancy outreach program. Journal of the Association for Research on Mothering, 11, 279–290.Google Scholar
  36. Singer, L. T., Moore, D. G., Fulton, S., Goodwin, J., Turner, J. J. D., Min, M. O., & Parrott, A. C. (2012). Neurobehavioral outcomes of infants exposed to MDMA (ecstasy) and other recreational drugs during pregnancy. Neurotoxicology and Teratology, 34(3), 303–310.  https://doi.org/10.1016/j.ntt.2012.02.001.CrossRefPubMedPubMedCentralGoogle Scholar
  37. Toro, R., Leonard, G., Lerner, J. V., Lerner, R. M., Perron, M., Pike, G. B., Richer, L., Veillette, S., Pausova, Z., & Paus, T. (2008). Prenatal exposure to maternal cigarette smoking and the adolescent cerebral cortex. Neuropsychopharmacology, 33, 1019–1027.  https://doi.org/10.1038/sj.npp.1301484.CrossRefPubMedGoogle Scholar
  38. Willford, J. A., Leech, S. L., & Day, N. L. (2006). Moderate prenatal alcohol exposure and cognitive status of children at age 10. Alcoholism: Clinical and Experimental Research, 30(6), 1051–1059.  https://doi.org/10.1111/j.1530-0277.2006.00119.x.CrossRefGoogle Scholar
  39. Wong, S., Ordean, A., & Kahan, M. (2011). Substance use in pregnancy. International Journal of Gynecology & Obstetrics, 114(2), 190–202.  https://doi.org/10.1016/j.ijgo.2011.06.001.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Kiri A. Latuskie
    • 1
    • 2
  • Tom Leibson
    • 2
  • Naomi C. Z. Andrews
    • 3
    • 4
  • Mary Motz
    • 4
    Email author
  • Debra J. Pepler
    • 3
  • Shinya Ito
    • 2
    Email author
  1. 1.Leslie Dan Faculty of PharmacyUniversity of TorontoTorontoCanada
  2. 2.Division of Clinical Pharmacology and ToxicologyHospital for Sick ChildrenTorontoCanada
  3. 3.Department of PsychologyYork UniversityTorontoCanada
  4. 4.Early Intervention DepartmentMothercraftTorontoCanada

Personalised recommendations